Theerapat Chanamuangkon

Mr. Theerapat Chanamuangkon

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Materials
Verified
Journal Article
Open access
PDF file
HCH-thaichnok Chunate
H-thaichnok Chunate
JKJirapon Khamwannah
Jirapon Khamwannah
AAAbdul Azeez Abdu Aliyu
Abdul Azeez Abdu Aliyu
STSaran Tantavisut
Saran Tantavisut
CPChedtha Puncreobutr
Chedtha Puncreobutr
BLBoonrat Lohwongwatana
Boonrat Lohwongwatana
The aim of this study is to synthesize Titania nanotubes (TNTs) on the 3D-printed Ti-6Al-4V surface and investigate the loading of antibacterial vancomycin drug dose of 200 ppm for local drug treatment application for 24 h. The antibacterial drug release from synthesized nanotubes evaluated via the chemical surface measurement and the linear fitting of Korsmeyer–Peppas model was also assessed. The TNTs were synthesized on the Ti-6Al-4V surface through the anodization process at different anodization time. The TNTs morphology was characterized using field emission scanning electron microscope (FESEM). The wettability and the chemical composition of the Ti-6Al-4V surface and the TNTs were assessed using the contact angle meter, Fourier transform infrared spectrophotometer (FTIR) and the X-ray photoelectron spectroscopy (XPS). The vancomycin of 200 ppm release behavior under controlled atmosphere was measured by the high-performance liquid chromatography (HPLC) and hence, the position for retention time at 2.5 min was ascertained. The FESEM analysis confirmed the formation of nanostructured TNTs with vertically oriented, closely packed, smooth and unperforated walls. The maximum cumulative vancomycin release of 34.7% (69.5 ppm) was recorded at 24 h. The wetting angle of both Ti-6Al-4V implant and the TNTs were found below 90 degrees. This confirmed their excellent wettability.

5 March 2024 in European Journal of Dentistry
Verified
Journal Article
Open access
PDF file
WWWarintorn Wichienrat
Warintorn Wichienrat
TSTheeraphat Surisaeng
Theeraphat Surisaeng
NSNoppadol Sa-Ard-Iam
Noppadol Sa-Ard-Iam
TCTheerapat Chanamuangkon
Theerapat Chanamuangkon
RMRangsini Mahanonda
Rangsini Mahanonda
WWWichaya Wisitrasameewong
Wichaya Wisitrasameewong
Objectives Ligature-induced periodontitis model has been widely used as a preclinical stage for investigating new treatment modalities. However, the effect of different ligature sizes on alveolar bone loss has never been studied. Therefore, we examined alveolar bone loss in this rat model using different sizes of silk ligatures, as well as healing after ligature removal. Materials and Methods Left maxillary second molars of Sprague-Dawley rats were ligated with 3-0, 4-0, or 5-0 silk ligatures (n = 4–5/group) for 14 days before harvested maxillae and gingival tissues. For subsequent experiment, animals were ligated for 14 days using the ligature size that induced the most alveolar bone loss before ligature removal and sacrificed at 0, 7 and 14 days (n = 5–6/group). All maxillae and gingival tissues were harvested to evaluate alveolar bone level, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) levels. Statistical Analysis Data was analyzed using SPSS Statistics 23.0 software (SPSS Inc., Chicago, Illinois, United States). Data from all experiments were tested for normality using Shapiro–Wilk test. Data between ligatured and nonligatured teeth were compared using Student's t-test or Wilcoxon signed-rank test. Differences among different ligature sizes were analyzed by analysis of variance followed by multiple comparisons with post-hoc test. A p-value less than 0.05 was considered statistically significant. Results The alveolar bone loss of ligated teeth was substantially higher than that of control after 14 days of ligation. While 3-0 and 4-0 resulted in significantly greater bone loss than 5-0 silk, the 3-0 group had the lowest rate of ligature loss. Therefore, alveolar bone healing postligature removal was investigated further using 3-0 silk. The results showed no significant bone level change at 2 weeks after ligature removal. In term of IL-1β and TNF-α levels, there was no statistically significant difference in IL-1β level between groups at any time point, while TNF-α was undetectable. Conclusion These data showed that 3-0 silk was the most effective ligature size in promoting alveolar bone loss comparing with 4-0 and 5-0 silk. During the 2-week period following ligature removal, spontaneous bone healing was not observed.

29 July 2023 in Materials Today Bio
Verified
Journal Article
Open access
SCSlila Chayanun
Slila Chayanun
TCTheerapat Chanamuangkon
Theerapat Chanamuangkon
BBBudsaraporn Boonsuth
Budsaraporn Boonsuth
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
BLBoonrat Lohwongwatana
Boonrat Lohwongwatana
Due to its superior mechanical properties and chemical stability, Polyetheretherketone (PEEK) has emerged as an alternative to conventional metal implants. However, the bio-inertness of PEEK's surface has limited its applications. Ambient sulfonation has been adopted to enhance bioactivity, but its nanoscale topographic changes are insufficient for implant-bone interlock. To further improve bone-implant interlock, this study employs CO2 laser machining to create sub-millimeter (0.5 mm) grooves on PEEK's surface, aiming to encourage bone ingrowth and strengthen the implant-bone interface. This research investigated the physical and chemical properties and bio-interaction of PEEK surface modified by sulfonation (SPEEK), laser machining (L-PEEK), and combination of both technique (L-SPEEK). X-ray photoelectron spectroscopy (XPS) spectra revealed that sulfonation compensates for the surface chemical shift instigated by laser ablation, aligning the surface chemistry of L-SPEEK with that of SPEEK. Furthermore, L-PEEK surfaces presented pores with sizes ranging from 1 to 600 μm, while SPEEK surfaces exhibited pores between 5 and 700 nm. All tested samples demonstrated non-cytotoxicity, with L-SPEEK exhibiting the highest mineralization and ALP activity as 2 and 2.1 times that of intrinsic PEEK, after 21 days of incubation. Microscopic imaging reveals a notably higher extracellular content on L-SPEEK compared to the other groups. This study underscores the potential of combining sub-millimeter laser machining with sulfonation in enhancing early osteogenic markers, providing a promising pathway for future PEEK-based orthopedic applications.

13 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
TSTeerawat Sukpaita
Teerawat Sukpaita
SCSuwabun Chirachanchai
Suwabun Chirachanchai
TCTheerapat Chanamuangkon
Theerapat Chanamuangkon
KNKatanchalee Nampuksa
Katanchalee Nampuksa
Naruporn MonmaturapojNaruporn Monmaturapoj
Naruporn Monmaturapoj
RARuchanee Salingcarnboriboon Ampornaramveth
Ruchanee Salingcarnboriboon Ampornaramveth
Bone tissue engineering is a complicated field requiring concerted participation of cells, scaffolds, and osteoactive molecules to replace damaged bone. This study synthesized a chitosan-based (CS) scaffold incorporated with trichostatin A (TSA), an epigenetic modifier molecule, to achieve promising bone regeneration potential. The scaffolds with various biphasic calcium phosphate (BCP) proportions: 0%, 10%, 20%, and 40% were fabricated. The addition of BCP improved the scaffolds’ mechanical properties and delayed the degradation rate, whereas 20% BCP scaffold matched the appropriate scaffold requirements. The proper concentration of TSA was also validated. Our developed scaffold released TSA and sustained them for up to three days. The scaffold with 800 nM of TSA showed excellent biocompatibility and induced robust osteoblast-related gene expression in the primary human periodontal ligament cells (hPDLCs). To evaluate in vivo bone regeneration potential, the scaffolds were implanted in the mice calvarial defect model. The excellent bone regeneration ability was further demonstrated in the micro-CT and histology sections compared to both negative control and commercial bone graft product. New bone formed in the CS/BCP/TSA group revealed a trabeculae-liked characteristic of the mature bone as early as six weeks. The CS/BCP/TSA scaffold is an up-and-coming candidate for the bone tissue engineering scaffold.

29 September 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
NINarin Intarak
Narin Intarak
TBThunyaporn Budsamongkol
Thunyaporn Budsamongkol
TTThanakorn Theerapanon
Thanakorn Theerapanon
TCTheerapat Chanamuangkon
Theerapat Chanamuangkon
ASAnucharte Srijunbarl
Anucharte Srijunbarl
Vorasuk ShotelersukVorasuk Shotelersuk
Vorasuk Shotelersuk

21 October 2024 in Soft Matter
Verified
Journal Article
Closed access
PDF file
PSPiyaporn Srisura
Piyaporn Srisura
YPYuwaporn Pinyakit
Yuwaporn Pinyakit
UNUmphan Ngoensawat
Umphan Ngoensawat
PYPongsakorn Yuntasiri
Pongsakorn Yuntasiri
KPKhoiria Nur Atika Putri
Khoiria Nur Atika Putri
VHVoravee Hoven
Voravee Hoven
Calcium phosphate (CaP) is a widely used biocompatible and bioactive material for bone tissue engineering due to its similarity to the mineral component of natural bone. Amorphous calcium phosphate is a highly reactive form of CaP that can undergo a phase transformation into a more stable crystalline phase, making it an attractive candidate for bone regeneration applications. However, amorphous CaP is highly unstable in aqueous solutions, which limits its use in practical applications. To overcome this limitation, this research aimed to employ carboxymethyl cellulose (CMC), a water-soluble biopolymer, as a stabilizer for CaP particles. CMC can form a protective layer around CaP particles, enhancing their stability and dispersion in aqueous solutions. An in situ wet chemical process was used to prepare CaP/CMC particles. A concentration of 500 mg L−1 of CMC was found to effectively stabilize the synthesized CaP particles, resulting in good dispersity. These particles were then integrated into an injectable hydrogel made of methacrylated hyaluronic acid (MeHA) to create a promising material for bone regeneration applications. The use of CaP and CMC in combination with an injectable MeHA hydrogel provides a promising approach to develop a stable, injectable material for bone regeneration.